H
ematopoietic development is regulated in large part by nuclear proteins that activate or repress sets of genes characteristic of distinct lineages. Studies of gene expression have formed the conceptual framework for investigating the transcriptional control of erythropoiesis (1, 2) . Among erythroid transcription factors, GATA-1 is of particular interest, because it is essential for erythropoiesis (3) . The Mediator complex is the key coactivator for many transcription factors (reviewed in refs. [4] [5] [6] [7] [8] . The interaction of activators with Mediator stimulates preinitiation complex assembly on promoter DNA. Mediator (TRAP/SMCC/DRIP/CRSP/NAT/ARC/ PC2) is a large (22-to 28-subunit) protein complex that binds RNA polymerase II (polII) and controls transcription from class II genes. It serves as an interface for regulatory factors and the polII. Substantial evidence argues that Mediator activates transcription, at least in part, by direct interactions with DNA-binding transcriptional activators bound at upstream promoter elements and enhancers with polII and one or more of the general initiation factors bound at the core promoter. Notably, different Mediator subunits are targets for interactions with the transcriptional activation domains of different DNA-binding transcriptional activators (4, 7, 9) . As a consequence, it is of great interest to identify subunits that serve as contact sites for the large collection of DNA-binding transcriptional activators. Prominent mammalian activators that interact with Mediator are the hormone receptors. For example, Med1/TRAP220 was shown to be required for the transcription of nuclear hormone receptor and PPAR␥ target genes but not for p53 or VP16 activated transcription (10, 11) . In another study, gene targeting of Med23 revealed an essential role in MAP kinase signaling through Elk-1, as well as for activation by the adenoviral E1A protein (12) .
Med1/TRAP220 is the main Mediator subunit target for nuclear receptors such as the thyroid hormone, estrogen, vitamin D, and retinoic acid receptors (6) . These receptors bind to and strongly rely on Mediator for their function. Recently, it was shown that Med1 exists predominantly in a Mediator subpopulation enriched in polII (13) . Previously, it was suggested that Med1 interacts not only with hormone receptors but also with GATA factors (14) . These data are supported by in vitro studies with Pit-1, GATA-2, and Med1 at the TSH␤ promoter (15) . Med1 deficiency leads to death at embryonic day 11.5. Although Med1 is not required for cell division, Med1 is critical for embryonic development of placental and cardiac development (10, 14, 16) .
Generation of mature red blood cells is a tightly regulated, multistep process. Erythroid cells derive from hematopoietic stem cells (Fig. 1B) . The first specific progenitors to be formed are referred to as erythroid burst-forming units (BFU-Es) (17, 18) . More committed erythroid precursor cells give rise to erythroid colony-forming units (CFU-Es) and can be prospectively isolated (19) . Later on in erythroid differentiation, erythroblasts extrude their nuclei and become reticulocytes, which further loose specific organelles to generate the fully mature circulating erythrocytes.
Erythrocyte differentiation is among the best-studied model systems used to define the mechanisms responsible for lineage commitment, cellular differentiation, and tissue-specific gene expression (reviewed in refs. 1, 2, and 20). The lineage-restricted transcription factor GATA-1 orchestrates several key aspects of erythroid development. Binding sites for GATA-1 are found in the regulatory regions of virtually all erythroid-cell-specific genes (21) . Mice deficient for GATA-1 succumb to fatal anemia because of an inability of erythroid precursor cells to survive and mature (22, 23) . Efforts to understand GATA-1 functions have identified a number of protein interactions with transcription factors or cofactors such as TAL-1, EKLF, PU.1, Sp1, and FOG-1 (reviewed in refs. 1 and 20) . GATA-1 is also reported to associate with chromatin remodeling proteins, including the CBP/p300 histone acetyltransferase and the SWI/SNF chromatin remodeling complex (24, 25) . GATA-1 is able to act not only as an activator but also as a repressor (26, 27) . Recently, a corepressor complex that can associate with GATA-1 by FOG-1 has been identified (27, 28) .
This study describes the role of the Mediator subunit Med1/ TRAP220 in erythropoiesis. Med1 deficiency leads to a defect in formation of erythroid colonies in methylcellulose assays. Med1 physically interacts with master regulator GATA-1 and GATA-1-dependent transcription is impaired in the absence of Med1. In addition, Mediator components are found in vivo at GATA-1-occupied enhancer sites. Therefore, we conclude that the Mediator complex, in particular subunit Med1, plays a pivotal role in GATA-1-mediated transcription. Previous studies have shown that ablation of Mediator subunit Med1 leads to embryonic death at day 11.5, which is caused by defects in placental and cardiac development (10, 16, 29) . Here, we show that at day 10.5, Med1-deficient embryos are phenotypical pale compared with wild-type embryos, especially visible in the heart region ( Fig.  1 A) . That prompted us to examine erythrocyte development in detail (Fig. 1B) . To exclude that this is due to a lack of stem cells in Med1-deficient embryos, we performed FACS analysis with the stem/progenitor marker c-Kit using yolk sac, aortagonads mesonephros (AGM) and fetal blood cells of 10.5 days postcoitum (dpc) embryos. In all three locations, c-Kitϩ progenitor cells were found in equal numbers, comparing both wild-type and Med1-deficient embryos (Fig. 2B and data not shown). In addition Med1 mRNA expression level remains constant during erythropoiesis as checked by RT-PCR (data not shown).
Results

Med1
Analysis of Fetal Day 10.5 Precursor Cells by Flow Cytometry and
Methylcellulose Assays. To investigate erythroid development in Med1-deficient embryos, we first established a FACS scheme to analyze and sort erythroid progenitor cells for functional methylcellulose assays. For the FACS-scheme erythroidspecific marker TER119 and transferrin receptor (CD71) were used, as described for definitive erythropoiesis (30) . To identify and sort progenitors from day 10.5 embryos, we used in addition to Ter119 and CD71 stem cell factor receptor c-Kit and panleukocyte marker CD45, which was found to be present also in the stem cell compartment (31) . An expression profile of these markers during erythroid development is depicted in Fig. 1C . In the fetal blood of day 10.5-dpc embryos, there are Ϸ1% of c-Kitϩ progenitor cells (Fig. 2 A) , which can be separated further in CD45ϩ and CD45-fractions. The sorted c-Kitϩ/CD45ϩ cells, staining negative for Ter119 and low for CD71, gave rise predominantly to BFU colonies and not CFU-Es [supporting information (SI) Fig. 6 ]. The c-Kitϩ/ CD45-population, low for Ter119 and high for CD71, gave rise to CFU-Es but scarcely to BFU colonies (SI Fig. 6 ). Using this scheme, we performed single-cell sorts into 96-well plates of the different cell populations mentioned above and assayed them for colony formation. Although the precursor cells are present in both Med1-deficient and wild-type embryos ( Fig. 2 B and D), we observed a 10ϫ reduction of CFU-E formation in the Med1-deficient cells (Fig. 2C ). For the BFU colonies, formation of myeloid and erythromyeloid colonies was normal, whereas formation of BFU-Es was 2-to 3-fold reduced (Fig. 2 E) . The absolute numbers of colonies formed from wild type with Med1-deficient progenitors can be seen in SI Table  1 . As an aside, we note that the efficiency of colony formation using embryonic c-Kitϩ cells is markedly higher than using cells from bone marrow (data not shown).
Med1 Physically Interacts with Erythroid Master Regulator GATA-1.
Next, we sought to investigate the molecular basis for the defective erythropoiesis in Med1-deficient embryos. Med1 is part of the Mediator complex that has been shown to interact with ligand-bound hormone receptor (reviewed in refs. 4 and 6) . Recently, two groups described an interaction between GATA factors and Med1 (14, 32) . Because GATA-1 is a master regulator in erythropoiesis, we investigated whether GATA-1 and Med1 can physically interact. To address this question, we used the yeast two-hybrid assay with four different regions of Med1 (amino acids 2-403, 386 -728, 680-1085, and 1099 -1560). Med1 fragments were fused to the Gal4 DNA-binding domain (bait), and GATA-1 was fused to the Gal4-activation domain (prey). Only amino acids 386 -728 of Med1 were able to interact with GATA-1 (Fig. 3A) . We verified these results using a GST-pulldown assays (SI Fig. 7) . In vitro-transcribed and -translated GATA-1 was offered to interact with different regions of Med1 fused to GST and immobilized on glutathione beads. We could narrow down the interaction region of Med1 to amino acids 622-701 (SI Fig. 7A ). In a modified GSTpulldown assay offering GST-GATA-1 and either HeLa nuclear extract (SI Fig. 7B ) or affinity-purified Mediator only (SI Fig. 7C ), endogenous Mediator binds to GATA-1. In further GST-pulldown assays using GST-GATA-1 and different in vitro synthesized Mediator subunits, not only Med1 but also Med17/TRAP80 and Med14/Rgr1/TRAP170 was found to interact with GATA-1 (Fig. 3B) . In contrast, Med4, Med7, Med8, Med15, Med23, and Med27 did not interact with GST-GATA-1. These results suggest that GATA-1 contacts not only one but at least three different Mediator subunits. GATA-1 harbors two zinc-finger domains; the C-terminal zinc finger is required for the binding to DNA, and the N-terminal zinc finger known to interact with FOG-1 and GATA-1 itself. Using GATA-1 mutants (delta N-terminal zinc finger, delta C-terminal zinc finger, and the C-terminal truncation lacking both the N-and C-terminal zinc fingers), we could show that the N-but not the C-terminal zinc finger of GATA-1 is required for interaction with Med1 (Fig. 3C) .
To investigate the association of endogenous Mediator with GATA-1 in vivo, we used the biotinylation tagging approach in erythroid cells (ref. 40 ; Fig. 3D ). Input and pulled-down proteins were analyzed by Western blot for the presence of Med1, GATA-1 (positive control), and DEK (negative control). Only GATA-1 and Med1 but not DEK are present in the pulled-down fraction (Fig. 3D, lane 2 , and data not shown).
Mediator Subunit Med1 Is Required for Transcriptional Activation by
GATA-1. We next tested whether the Mediator subunit is required for GATA-1 transcriptional activation at endogenous promoters and in a GATA-1 reporter assay (Fig. 4) . A real-time PCR-based reporter assay was used with the reporter plasmid pG-OVEC containing four copies of an optimal GATA-1-binding site (34) transfected into mouse embryonic fibroblasts (MEFs) together with (or without) GATA-1. A mutated plasmid (pmt-OVEC), to which GATA-1 can no longer bind, was used as a negative control (35) . The GATAresponsive promoter was activated only if GATA-1 was cotransfected in both Med1ϩ/ϩ (10-fold) and but not in Med1Ϫ/Ϫ MEFs (Fig. 4) . Importantly, GATA-1 transactivation function in Med1Ϫ/Ϫ MEFs was rescued by expression of either the full length human Med1 or the Med1 amino acids 1-670. The expression of the rabbit ␤-globin expression was increased up to 4-fold. The mutated pmtOVEC control plasmid was not activated in either of the different MEFs. Using the same reporter assay as in Fig. 4 , different GATA-1 constructs were tested. The deletion of the N-terminal zinc finger, shown to interact with Med1, leads to a complete abrogation of rabbit ␤-globin expression (SI Fig. 8 A) . The same is true for the C-terminal zinc-finger deletion mutant or C-terminal truncation mutant (Delta 208-end) lacking both Nand C-terminal zinc fingers.
To look at endogenous expression of GATA-1 target genes in Med1-deficient embryos, we sorted c-Kitϩ progenitor cells from the fetal blood of day 10.5 embryos (SI Fig. 8B ). As expected, the Med1 transcript is not present in the Med1-deficient embryos, whereas hypoxanthine phosphoribosyltransferase and c-Kit transcript levels are comparable with wild-type level. GATA-1 is known to positively autoregulate its own expression during erythroid differentiation (33) . Therefore, we observe not only a severe reduction of GATA-1 target genes ␤H1 globin and ␤-major globin but also a strong reduction in GATA-1 expression level.
Mediator Colocalizes with GATA-1 Regulatory Sequences in Vivo. To investigate whether the (activating) Med1-GATA-1 interaction correlates with colocalization in vivo, ChIP experiments were performed (Fig. 5) . First, we used bone marrow progenitor cells immortalized by transduction with HoxB4 (D.v.E., unpublished work) that were either noninduced ( Fig. 5A and  SI Fig. 9B ) or induced with erythropoietin for 3 days (Fig. 5B  and SI Fig. 9B ). Preliminary FACS and RT-PCR experiments suggest that these cells correspond to early committed erythroid progenitor cells. GATA-1 is specifically found to bind at enhancer elements Ϫ26 and Ϫ0.75 kb with respect to the start of transcription in the GATA-1 locus. Both polII and Mediator (subunits Med1 and Med17) are found to be present to Ϫ0.75 and ϩ0.08 kb but not at control sequences Ϫ14.4 and ϩ13.5 kb. Furthermore, in SI Fig. 9A , similar ChIP experiments were performed by using erythroid cells isolated from the spleen of phenylhydrazine-treated mice (36) . Erythroid (Ter119ϩ) cells were first enriched by depleting all other cell types with a mix of lineage markers. Strikingly, the overall ChIP profile of GATA-1, Med components, and polII looks similar to the profile obtained in erythropoietin-induced progenitor cells (Fig. 5B) . Similarly, ChIP experiments looking at the GATA-1 target gene ␤-globin show that Mediator subunits Med1 and Med17 as well as polII occupancy correlate with the presence of GATA-1 (SI Fig. 9B ).
Discussion
Because Med1 deficiency leads to a lack of erythroid precursors, we investigated whether Mediator subunit Med1 can directly interact with master regulator GATA-1 (Fig. 3) . In yeast two-hybrid and GST-pulldown assays, Med1 and GATA-1 interaction was clearly demonstrated and mapped. Interestingly, not only Med1 but also Med14 and Med17 interact with GATA-1. Other groups reported similar findings for activator-Mediator interactions, such as hormone receptor (Med1, Med14, and Med24), VP16 (Med25 and Med17), p53 (Med1 and Med17), and STAT2 (Med14 and Med17; summarized in ref. 4) . Therefore, it is a common theme that one activator contacts multiple Mediator subunits. Strikingly, often the same Mediator subunits (Med1, Med14, and Med17) are described as the Mediator interaction surface. It is likely that these three subunits are positioned on the surface of Mediator and have evolved to form physical contacts with diverse set of transcriptional regulators. Because Med1 interacts with the same region in GATA-1 like FOG-1 and GATA-1 itself (reviewed in ref. 20) , it will be interesting to find out whether Mediator binding can compete for the binding of these factors to GATA-1. Using a reporter assay in MEFs, Med1 is clearly an essential coactivator for GATA-1 (Fig. 4) . Interestingly, the dose of Med1 seems to be limiting, because heterozygous MEFs display only half the amount of transcriptional activation compared with wild-type MEFs (data not shown). In the Med1 rescue experiments, the N-terminal part of Med1 is surprisingly more effective than full length Med1 in rescuing transcriptional activation. The explanation for this difference might be because of the higher expression level of the Nterminal part (data not shown).
ChIP experiments were performed to verify whether the physical interaction between Med1 and GATA-1 also takes place in vivo (Fig. 5 and SI Fig. 9A ). GATA-1 is able to stimulate its own GATA-1 promoter activity (33) ; the GATA-1-binding sites could be systematically mapped on the GATA-1 gene locus (37) . We confirmed the described GATA recruitment to GATA-1 gene enhancer elements and found a clear correlation with the presence of Mediator subunits Med1 and Med17, as well as polII. Occupancy of GATA-1, Mediator, and polII is observed at element Ϫ0.75 and ϩ0.08 kb close to the promoter and, to a lesser extent, far upstream at Ϫ26 kb.
Preliminary data indicate that Mediator is also found at the GATA-2 promoter where GATA-1 is known to repress transcription (26) . The putative dual role of Mediator in activation and repression needs further investigation. Furthermore, our data reveal recruitment of polII to an enhancer far away from the core promoter. Similarly, it has been demonstrated that polII is recruited to the ␤-globin locus control region, and that this occupancy depends at least in part on the presence of GATA-1 (38) . Further support for polII occupancy at enhancers has been described for the androgen-specific gene PSA and for the TCR-␤ locus, both supported by in vivo footprinting and ChIP experiments (reviewed in ref. 39) .
We have identified a specific defect in the erythropoiesis of Mediator subunit Med1-deficient embryos at the CFU-E and also the BFU-E stage. We demonstrate that Mediator can physically interact with erythroid master regulator GATA-1 and is localized at the GATA-1 enhancer sites in erythroid cells by using ChIP experiments. In Med1-deficient cells, GATA-1-dependent transcriptional activation is defective in both reporter assays and endogenous GATA-1 target genes. Therefore, we conclude that Mediator subunit Med1 is crucial for erythropoiesis because it acts as a cofactor for master regulator GATA-1. In the future, conditional Med1-deficient mice will be instrumental in analyzing all hematopoietic lineages.
Materials and Methods
Animals and Tissue Preparation. Med1/TRAP220 heterozygous deficient mice were generated by Roeder and colleagues (10) . Embryos at 10.5 dpc, staged by somite counting, were dissected and genotyped by PCR. Embryonic yolk sac and AGM were isolated and digested with 0,1% collagenase D and DNase I in PBS/5% FCS at room temperature over 2 h. The cell suspension was filtered and stored on ice until further use. Embryonic blood was collected over 1 h by bleeding the headless embryo in PBS/5% FCS on ice. Methylcellulose Assays. Cells obtained as described above were cultured in methylcellulose (M3334; Stem Cell Technologies, Vancouver, BC, Canada) to investigate CFU-E and BFU colonyforming capacity. CFU-E assays were supplemented with 2 units erythropoietin (Epo)/ml and incubated over 2 days at 37°C with 5% CO 2 . BFU assays were performed by adding 2 units of Epo/ml and IL-3 (supernatant) over 8 days at 37°C with 5% CO 2 . The cultures were stained with benzidine (12% acetic acid containing 0.4% benzidine and 0.3% H 2 O 2 ) to indicate the amount of erythroid colonies.
GST-Pulldown and Biotinylation-Tagging Approaches. GST pulldown assays were performed as described in ref. 41 ChIP Assays. In the ChIP assays, we used either uninduced or HoxB4 cells (see below) induced with 3 units/ml EPO over 3 days. Chromatin preparation by using 1 ϫ 10 7 of the indicated cells was done with 0.4% formaldehyde for 10 min at room temperature. Sonication to Ϸ500-bp fragments and immunoprecipitations was performed as described in the Upstate Biotechnology (Lake Placid,
